179 related articles for article (PubMed ID: 18160997)
1. Polymorphisms of promoter and coding regions of the arylamine N-acetyltransferase 2 (NAT2) gene in the Indonesian population: proposal for a new nomenclature.
Yuliwulandari R; Sachrowardi Q; Nishida N; Takasu M; Batubara L; Susmiarsih TP; Rochani JT; Wikaningrum R; Miyashita R; Miyagawa T; Sofro ASM; Tokunaga K
J Hum Genet; 2008; 53(3):201-209. PubMed ID: 18160997
[TBL] [Abstract][Full Text] [Related]
2. N-acetyltransferase 2 polymorphism and acetylation profiles in Buginese ethnics of Indonesia.
Yuliwulandari R; Susilowati RW; Razari I; Viyati K; Umniyati H; Prayuni K
Ann Hum Genet; 2019 Nov; 83(6):465-471. PubMed ID: 31332782
[TBL] [Abstract][Full Text] [Related]
3. Study on Genotyping Polymorphism and Sequencing of N-Acetyltransferase 2 (NAT2) among Al-Ahsa Population.
Zahra MA; Kandeel M; Aldossary SA; Al-Taher A
Biomed Res Int; 2020; 2020():8765347. PubMed ID: 32626768
[TBL] [Abstract][Full Text] [Related]
4. Studies on N-Acetyltransferase (NAT2) Genotype Relationships in Emiratis: Confirmation of the Existence of Phenotype Variation among Slow Acetylators.
Al-Ahmad MM; Amir N; Dhanasekaran S; John A; Abdulrazzaq YM; Ali BR; Bastaki S
Ann Hum Genet; 2017 Sep; 81(5):190-196. PubMed ID: 28653770
[TBL] [Abstract][Full Text] [Related]
5. N-Acetyltransferase-2 (NAT2) gene polymorphisms and enzyme activity in Serbs: unprecedented high prevalence of rapid acetylators in a White population.
Djordjevic N; Carrillo JA; Ueda N; Gervasini G; Fukasawa T; Suda A; Jankovic S; Aklillu E
J Clin Pharmacol; 2011 Jul; 51(7):994-1003. PubMed ID: 20801937
[TBL] [Abstract][Full Text] [Related]
6. NAT2 and CYP2E1 polymorphisms associated with antituberculosis drug-induced hepatotoxicity in Chinese patients.
An HR; Wu XQ; Wang ZY; Zhang JX; Liang Y
Clin Exp Pharmacol Physiol; 2012 Jun; 39(6):535-43. PubMed ID: 22506592
[TBL] [Abstract][Full Text] [Related]
7. Identification of single-nucleotide polymorphisms (SNPs) of human N-acetyltransferase genes NAT1, NAT2, AANAT, ARD1 and L1CAM in the Japanese population.
Sekine A; Saito S; Iida A; Mitsunobu Y; Higuchi S; Harigae S; Nakamura Y
J Hum Genet; 2001; 46(6):314-9. PubMed ID: 11393533
[TBL] [Abstract][Full Text] [Related]
8. Arylamine N-acetyltransferase-2 genotypes in the Thai population.
Kukongviriyapan V; Prawan A; Tassaneyakul W; Aiemsa-Ard J; Warasiha B
Br J Clin Pharmacol; 2003 Mar; 55(3):278-81. PubMed ID: 12630978
[TBL] [Abstract][Full Text] [Related]
9. N-acetyltransferase 2 enzyme genotype-phenotype discordances in both HIV-negative and HIV-positive Nigerians.
Kotila OA; Fawole OI; Olopade OI; Ayede AI; Falusi AG; Babalola CP
Pharmacogenet Genomics; 2019 Jul; 29(5):106-113. PubMed ID: 30882558
[TBL] [Abstract][Full Text] [Related]
10. Arylamine N-acetyltransferase 2 gene polymorphism in an Algerian population.
Chelouti H; Khelil M
Ann Hum Biol; 2017 Sep; 44(6):531-536. PubMed ID: 28347189
[TBL] [Abstract][Full Text] [Related]
11. NAT2 variants are associated with drug-induced liver injury caused by anti-tuberculosis drugs in Indonesian patients with tuberculosis.
Yuliwulandari R; Susilowati RW; Wicaksono BD; Viyati K; Prayuni K; Razari I; Kristin E; Syafrizal ; Subagyo ; Sri Diana E; Setiawati S; Ariyani A; Mahasirimongkol S; Yanai H; Mushiroda T; Tokunaga K
J Hum Genet; 2016 Jun; 61(6):533-7. PubMed ID: 26911349
[TBL] [Abstract][Full Text] [Related]
12. Arylamine N-acetyltransferase 2 slow acetylator polymorphisms in unrelated Iranian individuals.
Bakayev VV; Mohammadi F; Bahadori M; Sheikholslami M; Javeri A; Masjedi MR; Velayati AA
Eur J Clin Pharmacol; 2004 Sep; 60(7):467-71. PubMed ID: 15316701
[TBL] [Abstract][Full Text] [Related]
13. Variation in NAT2 acetylation phenotypes is associated with differences in food-producing subsistence modes and ecoregions in Africa.
Podgorná E; Diallo I; Vangenot C; Sanchez-Mazas A; Sabbagh A; Černý V; Poloni ES
BMC Evol Biol; 2015 Dec; 15():263. PubMed ID: 26620671
[TBL] [Abstract][Full Text] [Related]
14. N-acetyltransferase 1 and 2 polymorphisms in para-substituted arylamine-induced contact allergy.
Westphal GA; Reich K; Schulz TG; Neumann C; Hallier E; Schnuch A
Br J Dermatol; 2000 Jun; 142(6):1121-7. PubMed ID: 10848734
[TBL] [Abstract][Full Text] [Related]
15. Genetic characterization of
Yuliwulandari R; Prayuni K; Razari I; Susilowati RW; Zulhamidah Y; Soedarsono S; Sofro ASM; Tokunaga K
Pharmacogenomics; 2021 Feb; 22(3):157-163. PubMed ID: 33399479
[No Abstract] [Full Text] [Related]
16. Genetic profile of the arylamine N-acetyltransferase 2 coding gene among individuals from two different regions of Brazil.
Teixeira RL; Miranda AB; Pacheco AG; Lopes MQ; Fonseca-Costa J; Rabahi MF; Melo HM; Kritski AL; Mello FC; Suffys PN; Santos AR
Mutat Res; 2007 Nov; 624(1-2):31-40. PubMed ID: 17509624
[TBL] [Abstract][Full Text] [Related]
17. The role of NAT2 polymorphism and methylation in anti-tuberculosis drug-induced liver injury in Mongolian tuberculosis patients.
Zhang D; Hao J; Hou R; Yu Y; Hu B; Wei L
J Clin Pharm Ther; 2020 Jun; 45(3):561-569. PubMed ID: 32364660
[TBL] [Abstract][Full Text] [Related]
18. Clarifying haplotype ambiguity of NAT2 in multi-national cohorts.
Selinski S; Blaszkewicz M; Agundez JA; Martinez C; Garcia-Martin E; Hengstler JG; Golka K
Front Biosci (Schol Ed); 2013 Jan; 5(2):672-84. PubMed ID: 23277078
[TBL] [Abstract][Full Text] [Related]
19. Polymorphism of the N-acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatotoxicity in Tunisian patients with tuberculosis.
Ben Mahmoud L; Ghozzi H; Kamoun A; Hakim A; Hachicha H; Hammami S; Sahnoun Z; Zalila N; Makni H; Zeghal K
Pathol Biol (Paris); 2012 Oct; 60(5):324-30. PubMed ID: 21856096
[TBL] [Abstract][Full Text] [Related]
20. Refinement of the prediction of N-acetyltransferase 2 (NAT2) phenotypes with respect to enzyme activity and urinary bladder cancer risk.
Selinski S; Blaszkewicz M; Ickstadt K; Hengstler JG; Golka K
Arch Toxicol; 2013 Dec; 87(12):2129-39. PubMed ID: 24221535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
